Photo of Steven (Steve) M. Hersch, MD, PhD

Steven (Steve) M. Hersch, MD, PhD

  • Director, NE Center of Excellence for Huntinton's Disease


Accepting New Patients




Clinical Interests
  • Huntington's disease
  • Neurodegenerative disorders
Medical Education
  • PhD, Boston University
  • MD, Boston University School of Medicine
  • Residency, Emory University Hospital
  • Fellowship, Emory University Hospital|Fellowship, Wesley Woods Geriatric Hospital
Board Certifications
  • Neurology
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Dr. Hersch's clinical and research interests are in neurodegenerative disorders and particularly Huntington's disease (HD). He was recruited to MGH/Harvard Medical School in 2001 to direct the HD clinical center and develop a laboratory devoted to translational research for HD. Dr. Hersch's work on HD has spanned basic, translational, and clinical and has included the neuropathology of HD, its pathogenesis, the development of therapeutics, and the development of clinical and biological measures of HD in humans to improve testing potential therapies.

His laboratory has examined the roles of huntingin protein in pathogenesis, the contributions of transcriptional dysfunction and cellular energetics to HD pathogenesis, and has extensively used HD mouse models to examine mechanisms of disease and explore potential therapies. Many of the compounds the Hersch lab has helped explore in HD mice are advancing through clinical trials. Dr. Hersch has been a principal investigator, steering committee member, or site investigator for many observational or therapeutic studies in HD patients. He has developed and holds INDs for potential disease modifying therapies for HD, which have gone to phase II and phase III clinical trials. He is leading a collaborative NIH supported program to develop neuroimaging, protein, small molecule, and genomic biomarkers of HD. He is also co-chair of the executive committee of the Huntington Study Group (HSG) and plays a major role in the planning and execution of multicenter clinical trials for HD. He also directs clinical care for HD provided by the New England Center of Excellence for Huntington's disease and sees patients in the Movement Disorders unit at MGH.

Edit Profile

Research & Publications

Research Summary
Dr. Hersch's clinical and research interests are in neurodegenerative disorders, particularly Huntington's disease (HD).  Visit the Hersch Lab to learn more.

Edit Profile

News & Events


Neurology Associates
15 Parkman Street
Boston MA, 02114-3117
Phone: 617-726-5532
Fax: 617-726-4101

Edit Profile

Back to Top